MMWR. Morbidity and mortality weekly report · 2016
Screening of Blood Donations for Zika Virus Infection - Puerto Rico, April 3-June 11, 2016.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kuehnert Matthew J, Basavaraju Sridhar V, Moseley Robin R, Pate Lisa L, Galel Susan A, Williamson Phillip C, Busch Michael P, Alsina Jose O, Climent-Peris Consuelo, Marks Peter W, Epstein Jay S, Nakhasi Hira L, Hobson J Peyton, Leiby David A, Akolkar Pradip N, Petersen Lyle R, Rivera-Garcia Brenda
Аннотация
Transfusion-transmitted infections have been documented for several arboviruses, including West Nile and dengue viruses (1). Zika virus, a flavivirus transmitted primarily by Aedes aegypti mosquitoes that has been identified as a cause of congenital microcephaly and other serious brain defects (2), became recognized as a potential threat to blood safety after reports from a 2013-2014 outbreak in French Polynesia. Blood safety concerns were based on very high infection incidence in the population at large during epidemics, the high percentage of persons with asymptomatic infection, the high proportion of blood donations with evidence of Zika virus nucleic acid upon retrospective testing, and an estimated 7-10-day period of viremia (3). At least one instance of transfusion transmission of Zika virus has been documented in Brazil after the virus emerged there, likely in 2014 (4). Rapid epidemic spread has followed to other areas of the Americas, including Puerto Rico.